<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font20 { font-size : 20; } .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font25">and </span>
   <span class="font20">influenza </span>
   <span class="font16">for </span>
   <span class="font16">virus </span>
   <span class="font13">with </span>
   <span class="font13">viral </span>
   <span class="font13">that </span>
   <span class="font13">viruses </span>
   <span class="font12">against </span>
   <span class="font12">resistance </span>
   <span class="font12">baloxavir </span>
   <span class="font12">clinical </span>
   <span class="font12">{background </span>
   <span class="font12">RNA </span>
   <span class="font11">are </span>
   <span class="font11">antiviral </span>
   <span class="font11">inhibitor </span>
   <span class="font11">from </span>
   <span class="font11">human </span>
   <span class="font11">treatment </span>
   <span class="font11">drug </span>
   <span class="font11">margin </span>
   <span class="font11">was </span>
   <span class="font11">have </span>
   <span class="font11">{border-style </span>
   <span class="font11">marboxil </span>
   <span class="font11">disease </span>
   <span class="font11">has </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">been </span>
   <span class="font11">efficacy </span>
   <span class="font11">high </span>
   <span class="font11">The </span>
   <span class="font11">activity </span>
   <span class="font11">endonuclease </span>
   <span class="font11">mutations </span>
   <span class="font11">replication </span>
   <span class="font11">Agents </span>
   <span class="font11">Infect </span>
   <span class="font11">Res </span>
   <span class="font11">both </span>
   <span class="font11">polymerase </span>
   <span class="font11">resistant </span>
   <span class="font11">respiratory </span>
   <span class="font11">IAV </span>
   <span class="font11">approved </span>
   <span class="font11">inhibitors </span>
   <span class="font11">risk </span>
   <span class="font10">oral </span>
   <span class="font10">were </span>
   <span class="font10">after </span>
   <span class="font10">neuraminidase </span>
   <span class="font10">ribonucleoside </span>
   <span class="font10">use </span>
   <span class="font10">Chemother </span>
   <span class="font10">Dis </span>
   <span class="font10">However, </span>
   <span class="font10">barrier </span>
   <span class="font10">circulating </span>
   <span class="font10">development </span>
   <span class="font10">escape </span>
   <span class="font10">infection </span>
   <span class="font10">into </span>
   <span class="font10">seasonal </span>
   <span class="font10">therapeutics </span>
   <span class="font10">uncomplicated </span>
   <span class="font10">analog </span>
   <span class="font10">antibody </span>
   <span class="font10">mitochondrial </span>
   <span class="font10">oseltamivir </span>
   <span class="font10">safety </span>
   <span class="font10">therapeutic </span>
   <span class="font10">this </span>
   <span class="font10">through </span>
   <span class="font10">Med </span>
   <span class="font10">adults </span>
   <span class="font10">cell </span>
   <span class="font10">highly </span>
   <span class="font10">low </span>
   <span class="font10">neutralizing </span>
   <span class="font10">novel </span>
   <span class="font10">px; </span>
   <span class="font10">strains </span>
   <span class="font10">these </span>
   <span class="font10">vitro </span>
   <span class="font10">{font-family </span>
   <span class="font10">A(HN) </span>
   <span class="font10">Influenza </span>
   <span class="font10">NAIs </span>
   <span class="font10">amantadine </span>
   <span class="font10">antibodies </span>
   <span class="font10">currently </span>
   <span class="font10">due </span>
   <span class="font10">during </span>
   <span class="font10">font-size </span>
   <span class="font10">group </span>
   <span class="font10">influenza: </span>
   <span class="font10">major </span>
   <span class="font10">pathogenic </span>
   <span class="font10">patients </span>
   <span class="font10">pediatric </span>
   <span class="font10">revealed </span>
   <span class="font10">studies </span>
   <span class="font10">target </span>
   <span class="font10">vaccine </span>
   <span class="font10">when </span>
   <span class="font10">which </span>
   <span class="font10">(Fig </span>
   <span class="font10">Although </span>
   <span class="font10">IBV </span>
   <span class="font10">Sci </span>
   <span class="font10">United </span>
   <span class="font10">Whereas </span>
   <span class="font10">acid </span>
   <span class="font10">airway </span>
   <span class="font10">approximately </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">but </span>
   <span class="font10">can </span>
   <span class="font10">class </span>
   <span class="font10">dose </span>
   <span class="font10">double; </span>
   <span class="font10">effects </span>
   <span class="font10">emerged </span>
   <span class="font10">frequency </span>
   <span class="font10">genetic </span>
   <span class="font10">groups </span>
   <span class="font10">host </span>
   <span class="font10">host-directed </span>
   <span class="font10">lower </span>
   <span class="font10">new </span>
   <span class="font10">next-generation </span>
   <span class="font10">not </span>
   <span class="font10">orally </span>
   <span class="font10">other </span>
   <span class="font10">patient </span>
   <span class="font10">primary </span>
   <span class="font10">protein </span>
   <span class="font10">resulting </span>
   <span class="font10">study </span>
   <span class="font10">such </span>
   <span class="font10">susceptibility </span>
   <span class="font10">trial </span>
   <span class="font10">viruses, </span>
   <span class="font10">(PO) </span>
   <span class="font10">Acad </span>
   <span class="font10">EIDD- </span>
   <span class="font10">Elsevier </span>
   <span class="font10">RdRP </span>
   <span class="font10">States </span>
   <span class="font10">This </span>
   <span class="font10">acute </span>
   <span class="font10">administration </span>
   <span class="font10">adverse </span>
   <span class="font10">all </span>
   <span class="font10">also </span>
   <span class="font10">animal </span>
   <span class="font10">avian </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">broadly </span>
   <span class="font10">cap-dependent </span>
   <span class="font10">cells </span>
   <span class="font10">characterization </span>
   <span class="font10">compound </span>
   <span class="font10">controlled </span>
   <span class="font10">different </span>
   <span class="font10">drugs </span>
   <span class="font10">experimental </span>
   <span class="font10">first </span>
   <span class="font10">fitness </span>
   <span class="font10">inhibition </span>
   <span class="font10">its </span>
   <span class="font10">lethal </span>
   <span class="font10">marboxil, </span>
   <span class="font10">mechanisms </span>
   <span class="font10">mutation </span>
   <span class="font10">phase </span>
   <span class="font10">population </span>
   <span class="font10">potential </span>
   <span class="font10">random </span>
   <span class="font10">severe </span>
   <span class="font10">signature </span>
   <span class="font10">since </span>
   <span class="font10">solid; </span>
   <span class="font10">some </span>
   <span class="font10">substitutions </span>
   <span class="font10">syncytial </span>
   <span class="font10">systematic </span>
   <span class="font10">thus </span>
   <span class="font10">tract </span>
   <span class="font10">transition </span>
   <span class="font10">upper </span>
   <span class="font10">vivo </span>
   <span class="font10">years </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">COVID- </span>
   <span class="font10">Ebola </span>
   <span class="font10">IAVs </span>
   <span class="font10">Natl </span>
   <span class="font10">These </span>
   <span class="font10">Virol </span>
   <span class="font10">addition </span>
   <span class="font10">analogs </span>
   <span class="font10">antivirals </span>
   <span class="font10">available </span>
   <span class="font10">bioavailable </span>
   <span class="font10">bold </span>
   <span class="font10">broad </span>
   <span class="font10">centre </span>
   <span class="font10">concerns </span>
   <span class="font10">conserved </span>
   <span class="font10">could </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">data </span>
   <span class="font10">demonstrated </span>
   <span class="font10">efficacious </span>
   <span class="font10">em; </span>
   <span class="font10">epithelium </span>
   <span class="font10">favipiravir </span>
   <span class="font10">free </span>
   <span class="font10">function </span>
   <span class="font10">harboring </span>
   <span class="font10">health </span>
   <span class="font10">hepatitis </span>
   <span class="font10">including </span>
   <span class="font10">increased </span>
   <span class="font10">infection, </span>
   <span class="font10">infections </span>
   <span class="font10">inhibits </span>
   <span class="font10">instance, </span>
   <span class="font10">load </span>
   <span class="font10">monoclonal </span>
   <span class="font10">most </span>
   <span class="font10">mutagenesis </span>
   <span class="font10">older </span>
   <span class="font10">over </span>
   <span class="font10">pandemic </span>
   <span class="font10">pimodivir </span>
   <span class="font10">pregnant </span>
   <span class="font10">preventing </span>
   <span class="font10">pt;} </span>
   <span class="font10">public </span>
   <span class="font10">recommended </span>
   <span class="font10">reduced </span>
   <span class="font10">reducing </span>
   <span class="font10">research </span>
   <span class="font10">residues </span>
   <span class="font10">resource </span>
   <span class="font10">review </span>
   <span class="font10">several </span>
   <span class="font10">signs. </span>
   <span class="font10">subunit </span>
   <span class="font10">targeting </span>
   <span class="font10">targets </span>
   <span class="font10">typically </span>
   <span class="font10">variants </span>
   <span class="font10">will </span>
   <span class="font10">year </span>
  </p>
 </body>
</html>
